Conformal photon-beam therapy with transverse magnetic fields: A Monte Carlo study

被引:25
作者
Li, XA
Reiffel, L
Chu, J
Naqvi, S
机构
[1] Exelar Corp, Chicago, IL 60614 USA
[2] Univ Maryland, Dept Radiat Oncol, Baltimore, MD 21201 USA
[3] Rush Univ, Dept Med Phys, Chicago, IL 60612 USA
关键词
conformal therapy; magnetic field; Monte Carlo;
D O I
10.1118/1.1344207
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This work studies the idea of using strong transverse magnetic (B) fields with high-energy photon beams to enhance dose distributions for conformal radiotherapy. EGS4 Monte Carlo code is modified to incorporate charged particle transport in B fields and is used to calculate effects of B fields on dose distributions for a variety of high-energy photon beams. Two types of hypothetical B fields, curl-free linear fields and dipole fields, are used to demonstrate the idea. The major results from the calculation for the linear B fields are: (I) strong transverse B fields (>1 T) with high longitudinal gradients (G) (>0.5 T/cm) can produce dramatic dose enhancement as well as dose reduction in localized regions for high-energy photon beams; (2) the magnitude of the enhancement (reduction) and the geometric extension and the location of this enhancement (reduction) depend on the strength and gradient of the B field, and photon-beam energy; (3) for a given B field, the dose enhancement generally increases with photon-beam energy; (4) for a 5 T B field with infinite longitudinal gradient (solenoidal field), up to 200% of dose enhancement and 40% of dose reduction were obtained along the central axis of a 15 MV photon beam; and (5) a 60% of dose enhancement was observed over a 2 cm depth region for the 15 MV beam when B = 5 T and G = 2.5 T/cm. These results are also observed, qualitatively, in the calculation with the dipole B fields. Calculations for a variety of B fields and beam configurations show that, by employing a well-designed B field in photon-beam radiotherapy, it is possible to achieve a significant dose enhancement within the target, while obtaining a substantial dose reduction over critical structures. (C) 2001 American Association of Physicists in Medicine.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 20 条